Inhalant use and addiction in Canada.
E
E
Weir
D000680:Amyl Nitrite / Q000009:adverse effects*; D002170:Canada / Q000453:epidemiology; D004638:Emergency Treatment / Q000379:methods; D006801:Humans; D020380:Needs Assessment; D009609:Nitrous Oxide / Q000009:adverse effects*; D009822:Oils, Volatile / Q000009:adverse effects*; D011203:Poverty / Q000517:prevention & control; D011322:Primary Prevention / Q000379:methods; D012997:Solvents / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy*
D009822:Oils, Volatile; D012997:Solvents; D000680:Amyl Nitrite; D009609:Nitrous Oxide